Casandra
Casandra Test Code PG42602Version 1 (DRAFT)
Performing Lab
Combined Pituitary Hormone Deficiency (CPHD) Panel
Clinical Use
Order TestUse
This test is designed for individuals who exhibit relevant clinical features or have a clinical or suspected diagnosis of Combined Pituitary Hormone Deficiency (CPHD). It is also suitable for patients with a growth hormone deficiency and a deficiency in at least one other pituitary hormone.
Special Instructions
Not provided.
Limitations
This panel analyzes a limited set of 9 genes known to be associated with CPHD. It doesn't encompass other genetic conditions or pituitary hormone deficiencies outside of this scope. False negatives are possible if mutations are outside interrogated regions or CNVs are not detected.
Test Details
New York Approved
Methodology
NGS (Targeted)
Biomarkers
DNA Sequencing and CNV Analysis • Targeted
Result Turnaround Time
14-21 days
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Whole Blood
Volume
Not provided
Minimum Volume
Not provided